The Venture Codex Logo

The Venture Codex

Welsh, Carson, Anderson & Stowe

599 Lexington Ave. Suite 1800, New York, NY, 10022, United States

Overview

Welsh, Carson, Anderson & Stowe is a private equity investment firm investing in information, business, and healthcare services companies. Since 1979, WCAS has been partnering with outstanding management teams to build leading healthcare and technology companies.

Total investments
5
Lead investments
3
Investments · 12mo
2
Active investors
10

Sector focus

  • Finance
  • Financial Services
  • Health Care
  • Venture Capital
Visit website

Investment portfolio

  • The Deployment Company

    Participated · Equity · May 2026

    The Deployment Company is a joint venture controlled by OpenAI and backed by 19 investors including major private equity firms and strategic partners. It is structured to combine OpenAI’s software with the distribution and portfolio access of private equity participants to accelerate enterprise AI deployment. The joint venture was valued at $10.0 billion before the new investment and raised over $4.0 billion in the reported transaction. Named investors include TPG, Brookfield Asset Management, Advent, Bain Capital, Dragoneer and SoftBank, alongside several consultancies. The firm aims to leverage the investors’ access to more than 2,000 companies to drive adoption of OpenAI’s tools. The raise follows significant recent financings involving OpenAI and comes as competitors such as Anthropic pursue similar partnerships.

  • Honest Health

    Participated · Equity · Feb 2026

    Founded in 2021, Honest Health partners with hospitals and provider groups to navigate value-based, risk-bearing reimbursement models. Its platform supplies clinicians with actionable analytics, operational support, and shared-accountability structures that prioritize quality and cost containment over volume. Led by CEO Rob Bessler, M.D., and backed by founders from Rubicon Founders, the company combines deep clinical expertise with scalable technology infrastructure. Honest Health’s services include care coordination tools and performance dashboards designed to improve patient outcomes and financial performance for health systems. The company has rapidly gained traction, prompting sizable investor interest. Proceeds from its latest funding will be used to expand into additional U.S. markets, form new partnerships with payers and providers, and further develop its technology and service offerings. No revenue or user metrics were disclosed in the article, but management cites “measurable improvements” in outcomes and cost savings as evidence of early success.

  • Revel Systems

    Led · Series C · Nov 2014

    Revel Systems offers a cloud-based POS solution that runs on iPad and bundles payroll, inventory and CRM functionality for restaurants, retailers and enterprise customers. The company positions its product as a way to bypass legacy POS hardware and long banking partner chains. Revel competes with Square, PayPal and First Data and counts customers such as Shell, Cinnabon, Estée Lauder, Tully’s, Smoothie King and Stanford University. WCAS says Revel has driven significant product innovation, market traction in key verticals and strong client growth in recent years. Private-equity backer Welsh, Carson, Anderson & Stowe has taken a majority stake and plans to fund and catalyze Revel’s next phase of growth, potentially pursuing larger-brand deals and a bigger tech exit. Revel Systems provides an iPad-based point-of-sale (POS) platform offering front-end order entry, payment processing and cash register functionality paired with back-end tools such as personnel scheduling, time clock and payroll management, inventory and product/menu management, and advanced reporting. Its platform is deployed in tens of thousands of locations across the United States and internationally. The company intends to use the latest funding to accelerate its global expansion and to support large enterprise engagements within both existing and new verticals. Revel serves SMBs, franchise operators and enterprises with enterprise-grade operations and reporting features to manage and grow their businesses. Founded in 2010 by Lisa Falzone and Chris Ciabarra, the company has steadily expanded its product suite and market presence. Revel Systems builds an iPad-based point-of-sale platform used by SMBs and larger retailers and restaurants such as Dairy Queen, Goodwill, and Smoothie King. The company has close to 10,000 terminals deployed, employs about 200 people, and is break-even on annual financials. Revel plans to expand globally with Europe as its next market and to ramp up product development. The new funding is aimed at aggressive hiring, including COO and CFO searches, and enlarging fulfillment and operations teams. Management is preparing the company for an initial public offering, which they anticipate in the next two to three years. WCAS’s involvement will also add an external board member to support growth and execution. Revel Systems provides an iOS-based iPad point-of-sale solution for restaurant, grocery and retail businesses. The platform integrates payroll, inventory tracking, customer relationship management and other back-office functions. Its Revel Marketplace enables direct integrations with third-party enhancements such as mobile payments, online ordering, gift and reward cards, and advanced financial software. Founded in 2010 by Lisa Falzone and Chris Ciabarra and based in San Francisco, the company targets merchants across retail and hospitality. Revel plans to expand sales and servicing capacity, grow nationwide and abroad by opening offices in Asia and Europe, and build a West Coast distribution center in addition to an existing facility in Orlando, Florida. It raised $10.1M in capital to fund this expansion. Revel Systems provides an iPad-powered, front-to-back-of-house POS platform including iPad software plus optimized hardware such as cash registers, weighing machines, and receipt printers. The platform can be customized for payroll, inventory tracking, web ordering, email receipts and other workflows. Revel is targeting chain restaurants and retail establishments with at least $500,000 in annual revenue and charges customers upwards of $3,000 for the full system plus a software licensing fee. The company positions its offering as a lower-cost alternative to traditional POS systems, which it says cost at least $6,000. Revel reports around $80 million in processing business with major brands and has been tapped by Beautiful Brands International to power POS systems across multiple franchised locations. The company launched in August 2011.

  • Lytx

    Led · Equity · Nov 2011

    Lytx develops video-driven telematics products used by driving fleets to monitor driving habits and collect driving data. The company’s technology is positioned around driver safety systems and fleet video telematics. In April 2018 Lytx raised a $700M funding round from a group of private equity investors. The funding gives Lytx an enterprise value in excess of $1.5 billion. Investors in the round included Clearlake Capital Group, HarbourVest Partners, Public Sector Pension Investment Board (PSP Investments), Guggenheim Investments and existing shareholder GTCR. Lytx said it was advised on the transaction by Rothschild & Co. and Kirkland & Ellis. Brandon Nixon remains chairman and CEO of the company. DriveCam, Inc. is a global driver risk management company based in San Diego, California. Its solution combines data and video analytics with real-time driver feedback and coaching to address causes of poor driving. DriveCam’s product is designed to prevent collisions and reduce fuel costs by improving how people drive. The company and Volvo Group have joined forces to deliver safety-centric solutions to the global commercial vehicle industry and pursue a shared goal of reducing accidents toward zero. The strategic investment from Volvo Group aims to support collaborative development efforts between the two companies. The article does not disclose DriveCam’s revenue or user metrics. DriveCam provides a video-based driver safety and risk management SaaS platform that combines data and video analytics with real-time driver feedback and coaching. Its solution aims to prevent collisions and reduce fuel costs by addressing causes of poor driving. The company reports deployment in over 170,000 commercial vehicles and says it has monitored and analyzed more than 4 billion driving miles, maintaining what it calls the world’s largest database of risky driving. DriveCam states it has achieved strong profitability, significant year-over-year growth and continues to win multi-year orders from new and existing clients. The company plans to expand into new market segments, broaden its value proposition through strategic partnerships and pursue targeted acquisitions, beginning with the announced purchase of RAIR. DriveCam will use the new investment to fund aggressive growth initiatives and the RAIR acquisition. DriveCam offers a behavior-based driver risk mitigation solution that uses sight and sound, expert analysis and driver coaching to predict and prevent risky driving behaviors likely to result in collisions. The company’s core product couples video and audio capture with expert review and coaching to change driver behavior and reduce incidents. DriveCam has developed deep industry expertise across a wide range of fleets, including transit; utilities and energy; trucking and distribution; solid waste; concrete and construction; telecom; residential and commercial services; and government and municipalities. The company received a $4M term loan from Leader Ventures. Leader Ventures is described as an investment firm offering blended debt and equity financing. CEO Brandon Nixon said the funding will help DriveCam continue to grow and help clients realize a 50% or greater reduction in costs associated with risky driving while improving road safety.

  • Valeritas

    Led · Series C · Sep 2011

    Valeritas makes V-Go, a disposable device for delivering basal-bolus insulin therapy in adults with Type 2 diabetes. The V-Go provides a continuous preset basal rate of insulin and allows on-demand bolus dosing around mealtimes, offering an alternative to multiple daily injections. Led by CEO Kristine Peterson, the company is based in Bridgewater, N.J. Valeritas closed a $100M structured debt financing with Capital Royalty L.P. The company intends to use the proceeds to further support U.S. commercialization of the V-Go. Valeritas previously raised $150M in equity financing in 2011. Valeritas develops drug-delivery solutions for diabetes, centered on its V-Go disposable insulin delivery device. The V-Go provides basal-bolus insulin therapy for adult patients who require insulin. The company intends to use the financing to support commercialization efforts for V-Go. Valeritas operates R&D and manufacturing in a facility in Shrewsbury, MA and is led by CEO Kristine Peterson. The company announced a $150M Series C financing in December 2011. As part of the transaction, Welsh, Carson, Anderson & Stowe will assume a controlling interest and a WCAS executive will join the board.

Team

  • Russell L. Carson

    General Partner

    LinkedIn
  • Bruce K. Anderson

    Founder & General Partner

  • Frances Higgins

    General Partner

  • Brian Kasser

    Talent Partner

    LinkedIn